tiprankstipranks
Nanobiotix SA ADR Reports 2024 Financial Results
PremiumCompany AnnouncementsNanobiotix SA ADR Reports 2024 Financial Results
18d ago
Nanobiotix: Strategic Partnerships and Clinical Advancements Drive Buy Rating
Premium
Ratings
Nanobiotix: Strategic Partnerships and Clinical Advancements Drive Buy Rating
19d ago
Nanobiotix Reports 2024 Progress and Financial Results
Premium
Company Announcements
Nanobiotix Reports 2024 Progress and Financial Results
19d ago
Nanobiotix Presents Promising Phase 1 Study Data on NBTXR3 at European Conference
PremiumCompany AnnouncementsNanobiotix Presents Promising Phase 1 Study Data on NBTXR3 at European Conference
1M ago
Nanobiotix’s Strategic and Financial Strength Bolstered by Janssen Licensing Agreement and Milestone Payments
Premium
Ratings
Nanobiotix’s Strategic and Financial Strength Bolstered by Janssen Licensing Agreement and Milestone Payments
1M ago
Strategic Licensing Amendment with Janssen Bolsters Nanobiotix’s Financial Outlook and Justifies Buy Rating
Premium
Ratings
Strategic Licensing Amendment with Janssen Bolsters Nanobiotix’s Financial Outlook and Justifies Buy Rating
1M ago
Nanobiotix files to sell 5.62M ordinary shares for holders
PremiumThe FlyNanobiotix files to sell 5.62M ordinary shares for holders
2M ago
Nanobiotix downgraded to Neutral from Buy at UBS
Premium
The Fly
Nanobiotix downgraded to Neutral from Buy at UBS
2M ago
Nanobiotix Releases Voting Rights and Shares Capital Update
Premium
Company Announcements
Nanobiotix Releases Voting Rights and Shares Capital Update
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100